Our new Director, Regulatory Services, Dr Greg Pearce, has written an article for Pharma in Focus on the challenges biosimilars pose for the Australian medicines industry. The article looks at the uncertainties that are yet to be resolved, as well as the standards Dr Pearce believes need to be developed.
This article is reproduced here with permission from Pharma in Focus.
Click here to read the article, Pharma in Focus – Australia must agree on biosimilar approach
